Travast Plus(Travoprost &Timolol)

Therapeutic Group: Ophthalmic

Presentation

Travast Plus Sterile Eye Drops: Each ml contains Travoprost USP 40 micrograms and Timolol Maleate BP equivalent to Timolol 5 mg.

Description

Travast Plus is a clear & colourless solution that contains two active ingredients- Travoprost and Timolol Maleate. These two drugs decrease raised pressure within the eye. They work in different ways to produce a combined effect greater than either medicine produces on its own.

Indications

Decrease of intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Dosage & Administration

Use in adults:
The dose is one drop of Travast Plus in the conjunctival sac of the affected eye(s) once daily, in the morning or evening. It should be administered at the same time each day.

Paediatric patients:
The efficacy and safety of Travast Plus in patients below the age of 18 years have not been established.

Side Effects

No serious ophthalmic or systemic undesirable effects related to Travast Plus were reported. The most frequently reported treatment-related undesirable effect was ocular hyperaemia. Other common side-effects may be keratitis, anterior chamber flare, eye pain, photophobia, eye swelling, conjunctival haemorrhage, corneal staining, ocular discomfort, visual acuity reduced, visual disturbance, blurred vision etc.

Precautions

Like other topically applied ophthalmic agents, Travoprost and Timolol are absorbed systemically. Due to the beta-adrenergic component, timolol, the same types of cardiovascular and pulmonary adverse reactions as seen with systemic beta adrenergic blocking agents may occur.

Use in Pregnancy & Lactation

There are no adequate data from the use of Travoprost in eye drops in pregnant women. Travast Plus should not be used during pregnancy unless clearly necessary.

It is unknown whether Travoprost from eye drops is excreted in human breast milk. Timolol is excreted in breast milk.The use of Travast Plus by breast-feeding women is not recommended.

Drug Interaction

No specific interaction was observed with Travast Plus eye drops.

Over Dose

Incase of overdose with Travast Plus, treatment should be symptomatic.

Storage

Store in a cool, dry place, away from heat and direct light. Keep out of the reach of children. Do not use more than 4 weeks after opening the bottle

Commercial Pack

Travast Plus Sterile Eye Drops: Plastic dropper bottle containing 3 ml eye drops.